Liens rapides
Catégories
Fiches d'information
Les fiches d'information fournissent des informations supplémentaires sur l'industrie mondiale des protéines plasmatiques thérapeutiques.
Publications et présentations
Discover the main highlights of our industry in our latest publications.
Ressources pour les patients
Explorez les ressources de PPTA pour les patients intéressés par les thérapies aux protéines plasmatiques.
Rapports des parties prenantes
Apprenez-en plus en accédant à la collection de rapports de l'industrie.
Actualités et communiqués de presse
Restez au courant de l'actualité et des événements de l'Association.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Mar 15, 2022
PPTA’s Plasmavigilance Program: Adverse events among U.S. Source plasma donors
All
Publication
https://plasmaprotein.sharepoint.com/sites/COMMS/cd/Forms/AllItems.aspx?id=%2Fsites%2FCOMMS%2Fcd%2FSource%20Magazine%2FPublication%20%28permanent%29%2FSource%5FSpring%202022%2Epdf&parent=%2Fsites%2FCOMMS%2Fcd%2FSource%20Magazine%2FPublication%20%28permanent%29&p=true&ga=1
Mar 15, 2022
PPTA’s Plasmavigilance Program: Adverse events among U.S. Source plasma donors
All
Publication
https://plasmaprotein.sharepoint.com/sites/COMMS/cd/Forms/AllItems.aspx?id=%2Fsites%2FCOMMS%2Fcd%2FSource%20Magazine%2FPublication%20%28permanent%29%2FSource%5FSpring%202022%2Epdf&parent=%2Fsites%2FCOMMS%2Fcd%2FSource%20Magazine%2FPublication%20%28permanent%29&p=true&ga=1
Mar 1, 2022
The Source Spring 2022
Magazine of the plasma protein therapeutics industry - Spring 2022
All
The Source Magazine
https://drive.google.com/file/d/1YYNlKYft6GGiSCcPDRt-OaopCQ9e8xOR/view?usp=sharing
Mar 1, 2022
The Source Spring 2022
Magazine of the plasma protein therapeutics industry - Spring 2022
All
The Source Magazine
https://drive.google.com/file/d/1YYNlKYft6GGiSCcPDRt-OaopCQ9e8xOR/view?usp=sharing
Feb 18, 2022
PPTA Leadership Update – Amy Efantis
Dear PPTA Members and Patient Stakeholders, We are writing to you today to inform you that Amy Efantis, PPTA’s president & CEO, recently informed the Global Board of Directors of her decision to leave the association.
All
PPTA statements
Feb 18, 2022
PPTA Leadership Update – Amy Efantis
Dear PPTA Members and Patient Stakeholders, We are writing to you today to inform you that Amy Efantis, PPTA’s president & CEO, recently informed the Global Board of Directors of her decision to leave the association.
All
PPTA statements
Feb 16, 2022
PPTA Disagrees with Ruling from Romanian Competition Council
The Plasma Protein Therapeutics Association (PPTA) disagrees with the 15 February 2022 ruling from the Romanian Competition Council (RCC) finding that PPTA directed manufacturers to withhold immunoglobulin (Ig) therapies from the Romanian market to force repeal of the so-called “clawback” tax.
All
PPTA statements
Feb 16, 2022
PPTA Disagrees with Ruling from Romanian Competition Council
The Plasma Protein Therapeutics Association (PPTA) disagrees with the 15 February 2022 ruling from the Romanian Competition Council (RCC) finding that PPTA directed manufacturers to withhold immunoglobulin (Ig) therapies from the Romanian market to force repeal of the so-called “clawback” tax.
All
PPTA statements
Aucun résultat n'a été trouvé